Runnebaum, Ingo B. 1960-
Ingo B. Runnebaum
VIAF ID: 4921147270513835700002 (Personal)
Permalink: http://viaf.org/viaf/4921147270513835700002
Preferred Forms
- 100 0 _ ‡a Ingo B. Runnebaum
- 100 1 _ ‡a Runnebaum, Ingo B. ‡d 1960-
4xx's: Alternate Name Forms (13)
5xx's: Related Names (7)
- 551 _ _ ‡a Jena ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Klinik für Frauenheilkunde und Geburtshilfe ‡g Jena ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Köln ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 500 1 _ ‡a Runnebaum, Benno ‡d 1933- ‡4 bezf ‡4 https://d-nb.info/standards/elementset/gnd#familialRelationship ‡e Beziehung familiaer
- 500 1 _ ‡a Runnebaum, Hedwig ‡d 1938- ‡4 bezf ‡4 https://d-nb.info/standards/elementset/gnd#familialRelationship ‡e Beziehung familiaer
- 500 1 _ ‡a Runnebaum, Silke ‡d 1970- ‡4 bezf ‡4 https://d-nb.info/standards/elementset/gnd#familialRelationship ‡e Beziehung familiaer
- 510 2 _ ‡a Universitätsklinikum Jena ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer : randomized clinical trial | |
Antigene der Spermatozoonoberfläche Nachweis von Concanavalin-A-Rezeptoren durch monoklonale und polyklonale Antikörper | |
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes | |
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study | |
BRCA1 promoter methylation and clinical outcomes in ovarian cancer: an individual patient data meta-analysis | |
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer | |
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer | |
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer | |
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk | |
Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status | |
Differenzierte Betrachtung der Lernkurven eines erfahrenen offen-Operateurs bei Einführung des Roboting am Beispiel der radikalen Prostatektomie | |
Diffusions Tensor Bildgebung der Mamma eine Pilotstudie | |
Einfluss von Fenchel (Foeniculum vulgare) auf eine benigne hormonrezeptorpositive- und -negative Mammazelllinie (MCF10a uund MCF 12a) | |
Endometriose - Symptomatik und Lebensqualität vor und nach Diagnosestellung in Abhängigkeit von Stadium und Kinderwunsch an der Universitätsfrauenklinik Jena : Ergebnisse einer Studie von 182 Patienten | |
Endometriosis reduces ovarian response in controlled ovarian hyperstimulation independent of AMH, AFC, and women's age measured by follicular output rate (FORT) and number of oocytes retrieved | |
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study | |
Evaluation der krankheitsbezogenen Lebensqualität nach uteriner Arterienembolisation (UAE) als singuläre Therapie sowie in Kombination mit einer temporären präoperativen uterinen Arterienembolisation (tp-UAE) in Kombination mit einer Myomektomie | |
Evaluation of Integrated HPV DNA as Individualized Biomarkers for the Detection of Recurrent CIN2/3 during Post-Treatment Surveillance | |
Extensive endometriosis surgery: rASRM and Enzian score independently relate to post-operative complication grade | |
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk | |
Five endometrial cancer risk loci identified through genome-wide association analysis | |
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers | |
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. | |
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer | |
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. | |
Hirnmetastasen beim Mammakarzinom : Auftreten, Therapie und Prognose der letzten 10 Jahre : Zuarbeit zur Studie GBG79 Brainmet Register aus den Daten des Tumorzentrums Gera | |
How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. | |
Identification of nine new susceptibility loci for endometrial cancer | |
The influence of medical informed consent discussion on postoperative satisfaction and quality of life of patients with uterine fibroids after myomectomy or hysterectomy | |
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study | |
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o | |
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years | |
ITIH5 shows tumor suppressive properties in cervical cancer cells grown as multicellular tumor spheroids | |
Konzept der primären ultraradikalen Chirurgie des neu diagnostizierten fortgeschrittenen Ovarialkarzinoms mit dem Ziel der makroskopischen Komplettresektion an der Frauenklinik des Universitätsklinikums Jena onkologische Ergebnisse und gynäkologisch-chirurgische Parameter zur Risikoeinschätzung hinsichtlich Morbidität und Mortalität | |
Laparoskopisch assistierte vaginale Hysterektomie mit Salphingektomie versus ohne Salphingektomie | |
Lebensqualität und Ernährungsgewohnheiten von Frauen mit polyzystischem Ovarialsyndrom | |
Lebensqualitätsbeurteilung von Mammakarzinom-Patientinnen am interdisziplinären Brustzentrum Jena prospektive Analyse von Studien-Patientinnen versus Nicht-Studien-Patientinnen; hat die Studienteilnahme einen Einfluss auf die Lebensqualität? | |
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500 | |
Loss of gene function as a consequence of human papillomavirus DNA integration. | |
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer | |
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse | |
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk | |
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | |
Non-random integration of the HPV genome in cervical cancer | |
Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis | |
Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer) | |
Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO. | |
P53-Gen ist ein Tumorsuppressor und Zellzyklusregulator in Brustkrebszellen" | |
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS | |
A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer | |
Polymorphisms in inflammation pathway genes and endometrial cancer risk | |
Post-treatment human papillomavirus antibody kinetics in cervical cancer patients | |
Prävention medizinischer Behandlungsfehler : ein systematisches Revies zur Identifikation von Fehlercharakteristika zwecks gezielter Intervention | |
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. | |
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status | |
Prognostische Wertigkeit des suprarenalen Lymphknotenbefalls bei Patientinnen mit Zervixkarzinom | |
Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types | |
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms | |
Response | |
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10 | |
role of laparoscopy in the management of borderline ovarian tumors | |
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology | |
sekundäre Armlymphödem nach Mammakarzinombehandlung Nachuntersuchung eines Patientengutes der Universitätsfrauenklinik Jena Operationszeitraum 2000 bis 2005 | |
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer | |
Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study | |
Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands | |
Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study. | |
Two novel unbalanced whole arm translocations are frequently detected in cervical squamous cell carcinoma | |
Unexpected coexistent endometriosis in women with symptomatic uterine leiomyomas is independently associated with infertility, nulliparity and minor myoma size | |
Untersuchung von Methylierungsmarkern für den Nachweis von Ovarialkarzinomen anhand von Bauchraumspülflüssigkeiten | |
Updated Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO) and the Gynecological Endoscopy Working Group (AGE) of the German Society of Gynecology and Obstetrics (DGGG) on the Randomized Study Comparing Minimally Invas | |
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility | |
Vergleich der diagnostischen Genauigkeit von konventioneller Röntgenmammographie mit der MR-Mammographie im Langzeitverlauf | |
Vergleichende Analyse der morphologischen und dynamischen Charakteristika von Brustläsionen, die mittels 1,5 vs. 3 T MRT bioptiert wurden : Unterschiede und Gemeinsamkeiten im diagnostischen Outcome und in der Machbarkeit der Intervention | |
Verhalten der zirkulierenden epithelialen Tumorzellen unter der neoadjuvanten Therapie und der Nachbeobachtung bei Patientinnen mit Her2/neu-positivem Brustkrebs und Korrelation zum progressionsfreien Überleben | |
Wertigkeit des C-reaktiven Proteins als zusätzlicher diagnostischer Parameter bei der Auswertung der dynamischen MR-Mammographie eine klinisch-histopathologisch-radiologische Korrelation | |
What is the evidence for lymphadenectomy in presumed early ovarian cancer? | |
প্রত্যুত্তর |